Nano Dimension Announced Q3 2022 Revenue of $10M & Record Backlog

Rhea-AI Summary

Nano Dimension reported Q3 2022 revenues of $10 million, a remarkable 646% increase year-over-year, though 10% lower than Q2 2022. Year-to-date revenue reached $31.5 million, a 964% rise compared to the same period in 2021. However, the net loss before tax was $67.1 million, and adjusted EBITDA stood at negative $24.2 million. Supply chain issues and geopolitical conflicts impacted earnings, notably a 75% revenue decline in certain European markets. The company has a backlog of approximately $9 million, indicating potential future growth.

Positive

• Q3 2022 revenue increased by 646% compared to Q3 2021.
• Year-to-date revenue was $31.5 million, reflecting a 964% increase year-over-year.
• Record backlog of approximately $9 million indicates strong future demand.

Negative

• Net loss before tax for Q3 was $67.1 million.
• Adjusted EBITDA for Q3 was negative $24.2 million.
• Revenue in Russia and Poland decreased by 75% due to geopolitical tensions.

646% Higher over Q3 Last Year
964% Higher YTD 2022 vs. Same Period 2021

Conference call to be held today at 9:00 a.m. EDT

WALTHAM, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), an industry leader in Additively Manufactured Electronics, additive PCB assembly & printhead drivers and software (AME), and a supplier of Additive Manufacturing machines and materials (AM), today announced financial results for the third quarter ended September 30^th, 2022. 

Nano Dimension reported revenues of $10M for the third quarter of 2022, an increase of 646% over the same quarter in 2021 and 10% less than Q2/2022. Moreover, the 3^rd quarter of 2022 revenue run-rate indicates the potential for growth of approximately 300% in full year 2022 over 2021. If this occurs, the Company’s revenue will be growing over 10 times from 2020 to 2022, assuming no critical changes in the world economy resulting from current international affairs and/or other factors.

Revenues for the nine months period ended September 30^th, 2022, were $31.5M, which represent a 964% increase over the nine months period ended September 30^th, 2021.

Total loss before tax for the 3^rd quarter of 2022 was $67.1M.

• Adjusted EBITDA for the 3^rd quarter of 2022 was negative $24.2M, excluding $42.9M of non-cash adjustments for finance expenses/income for revaluation of assets and liabilities, share-based payments, exchange rate differences, interest income and depreciation and amortization expenses.
• Adjusted EBITDA as above includes R&D cash expenses of $13.5M.
• Net cash used in operations during the 3^rd quarter of 2022 was $22.3M.
  

Details regarding EBITDA and Adjusted EBITDA can be found later in this press release under “Non-IFRS measures.”

Yoav Stern, Chairman & CEO, comments: “The comparable increases of revenue of Q3 2022 over Q3 2021 (646%) and year-to-date over last-year-year-to-date (964%) - highlight the business’ continued success in growing dramatically, better than our expectations as expressed last year. We also finished the third quarter with a record backlog of approximately $9M.

All our product lines’ revenue grew organically exceptfor additive electronics machines in Europe: As a result of the Russia-Ukraine war, our revenues in Russia and Poland were reduced in the first 9 months of 2022 by approximately $1.5M (75%) compared to the same period in 2021. Additionally, we understand from other customers there that the continued components’ supply chainshortages have caused them to request a delay in delivery of additive electronic machines (which are used to mount those delayed components).

Sales and deliveries in the USA of similar machines grew organically by 45% over the 9 months ended September 30^th, 2022, compared to the similar period in 2021.  

The Gross Margin is a bit lower than we have anticipated, which is a result of the above mentioned held-back deliveries in Europe without reducing the fixed manufacturing overhead. The inherent gross margin of that technology is above 30%, as it has been for years, and it is within the typical range for that industry segment. We sold 69 machines of this kind since 1-1-2022. The Q3/2022 lower gross margin is also a result of trading up old AME machines with new ones, which are transactions at lower gross margins than the regular new AME machine sales.” 

FINANCIAL RESULTS:

Third Quarter 2022 Financial Results

• Total revenues for the third quarter of 2022 were $9,998,000, compared to $11,101,000 in the second quarter of 2022, and $1,340,000 in the third quarter of 2021. The decrease compared to the second quarter of 2022 was influenced by the conflict in Europe and supply chain delays, as explained above. The increase compared to the third quarter of 2021 is attributed to increased sales of the Company’s product lines.
  
  
• Cost of revenues (excluding amortization of intangibles) for the third quarter of 2022 was $7,428,000, compared to $7,151,000 in the second quarter of 2022, and $696,000 in the third quarter of 2021. The increase is attributed mostly to the increased sales of the Company’s product lines.
  
  
• Research and development (R&D) expenses for the third quarter of 2022 were $18,535,000, compared to $18,365,000 in the second quarter of 2022, and $13,726,000 in the third quarter of 2021. The increase compared to the second quarter of 2022 is attributed to an increase in materials and subcontractors’ expenses, as well as an increase in depreciation expenses, partially offset by a decrease in share-based payment expenses. The increase compared to the third quarter of 2021 is attributed mainly to an increase in payroll expenses and subcontractors expenses and is partially offset by a decrease in depreciation and share-based payment expenses.
  
  
  • The R&D expenses includes depreciation and share-based payments expenses of $5,057,000.
    
    
• Sales and marketing (S&M) expenses for the third quarter of 2022 were $9,652,000, compared to $10,115,000 in the second quarter of 2022, and $6,301,000 in the third quarter of 2021. The decrease compared to the second quarter of 2022 is attributed mainly to the decrease in marketing and share-based payment expenses, partially offset by an increase in payroll expenses. The increase compared to the third quarter of 2021 is attributed mainly to an increase in payroll and marketing related expenses as well as an increase in depreciation, partially offset by a decrease in share-based payment expenses.
  
  
  • The S&M expenses includes depreciation and share-based payments expenses of $1,941,000.
    
    
• General and administrative (G&A) expenses for the third quarter of 2022 were $7,417,000, compared to $7,207,000 in the second quarter of 2022, and $4,843,000 in the third quarter of 2021. The increase compared to the third quarter of 2021 is attributed to an increase in payroll and professional services due to the Company’s latest acquisitions, as well as an increase in office expenses.
  
  
  • The G&A expenses includes depreciation and share-based payments expenses of $1,604,000.
    
    
• Net loss attributed to the owners for the third quarter of 2022 was $66,931,000, or $0.26 per share, compared to $39,732,000, or $0.15 per share, in the second quarter of 2022, and $18,237,000 or $0.07 per share, in the third quarter of 2021.
  
  
  • Adjusted EBITDA for the 3^rd quarter of 2022 was negative $24.2M, excluding $42.9M of non-cash adjustments for finance expenses/income for revaluation of assets and liabilities, share-based payments, exchange rate differences, and depreciation and amortization expenses.

Nine Months Ended September 30 2022, Financial Results

• Total revenues for the nine months period ended September 30th, 2022, were $31,529,000, compared to $2,962,000 in the nine months period ended September 30th, 2021. The increase is attributed to increased sales of the Company’s product lines.
  
  
• Cost of revenues (excluding amortization of intangibles) for the nine months period ended September 30^th, 2022, was $21,159,000, compared to $1,380,000 in the nine months period ended September 30^th, 2021. The increase is attributed mostly to increased sales of the Company’s product lines.
  
  
• R&D expenses for the nine months period ended September 30^th, 2022, were $54,770,000, compared to $26,587,000 in the nine months period ended September 30, 2021. The increase is attributed to an increase in payroll and subcontractors’ expenses as well as an increase in share-based payment expenses, as a result of the Company’s increased R&D efforts.
  
  
  • The R&D expenses for the nine months period ended September 30^th, 2022 includes depreciation and share-based payments expenses of $16,625,000.
    
    
• S&M expenses for the nine months period ended September 30, 2022, were $29,075,000, compared to $15,023,000 in the nine months period ended September 30, 2021. The increase is attributed to an increase in payroll and marketing expenses as well as an increase in share-based payment expenses as a result of the Company’s growing sales and marketing team.
  
  
  • The S&M expenses for the nine months period ended September 30^th, 2022 includes depreciation and share-based payments expenses of $7,682,000.
    
    
• G&A expenses for the nine months period ended September 30^th, 2022, were $21,366,000, compared to $13,174,000 in the nine months period ended September 30^th, 2021. The increase is attributed to an increase in payroll expenses as well as an increase in office and rent and related expenses, and professional services.
  
  
  • The G&A expenses for the nine months period ended September 30^th, 2022 includes depreciation and share-based payments expenses of $4,962,000.
    
    
• Net loss attributed to the owners for the nine months period ended September 30^th, 2022, was $139,756,000, or $0.54 per share, compared to $41,153,000, or $0.17 per share, in the nine months period ended September 30^th, 2021.
  
  
  • Adjusted EBITDA for the nine months period ended September 30th, 2022 was negative $64.7M, excluding $76.5M of non-cash adjustments for finance expenses/income for revaluation of assets and liabilities, share-based payments, exchange rate differences, and depreciation and amortization expenses.

Balance Sheet Highlights

• Cash and cash equivalents, together with short and long-term unrestricted bank deposits totaled $1,048,712,000 as of September 30^th, 2022, compared to $1,355,595,000 as of December 31^st, 2021. The decrease compared to December 31^st, 2021, mainly reflects cash used in operating activities and investing activities.
  
  
• Shareholders’ equity totaled $1,230,716,000 as of September 30^th, 2022, compared to $1,343,356,000 as of December 31^st, 2021.

Conference call information

The Company will host a conference call to discuss these financial results today, December 1^st, 2022, at 9:00 a.m. EDT (4:00 p.m. IDT).
We encourage participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10172491/f4dc959048.
Webcast link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=dJL0SDBd.
U.S. Dial-in Number: 844-695-5517, INTERNATIONAL DIAL IN: 1-412-902-6751, Israel Dial-in Number: 1-80-9212373. Please request the “Nano Dimension NNDM call” when prompted by the conference call operator. For those unable to participate in the conference call, there will be a replay available from a link on Nano Dimension’s website at http://investors.nano-di.com/events-and-presentations.

About Nano Dimension
Nano Dimension’s (Nasdaq: NNDM) vision is to transform the electronics and similar additive manufacturing sectors through the development and delivery of an environmentally friendly and economically efficient additive manufacturing, Industry 4.0 solution, while enabling a one-production-step-conversion of digital designs into functioning devices – on demand, anytime, anywhere.                    

The DragonFly IV^® system and specialized materials serve cross-industry High-Performance-Electronic-Devices (Hi-PEDs^®) fabrication needs by simultaneously depositing proprietary conductive and dielectric substances, while integrating in-situ capacitors, antennas, coils, transformers, and electromechanical components. The outcomes are Hi-PEDs^® which are critical enablers of autonomous intelligent drones, cars, satellites, smartphones, and in vivo medical devices. In addition, these products enable iterative development, IP safety, fast time-to-market, and device performance gains. 

Nano Dimension also develops complementary production equipment for Hi-PEDs^® and printed circuit board (PCB) assembly (Puma, Fox, Tarantula, Spider etc.). The core competitive edge for this technology is in its adaptive, highly flexible surface-mount technology (SMT) pick-and-place equipment, materials dispenser suitable for both high-speed dispensing and micro-dispensing, as well as an intelligent production material storage and logistics system.  Nano Dimension is a leading developer and supplier of high-performance control electronics, software, and ink delivery system. It invents and delivers state-of-the-art 2D and 3D printing hardware and unique operating software.  It focuses on high-value, precision-oriented applications such as specialized direct-to-container packaging, printed electronics functional fluids, and 3D printing, all controlled by the proprietary software system - Atlas.

Serving similar users of Hi-PEDs^®, Nano Dimension’s AM products include Fabrica 2.0 micro additive manufacturing system enables the production of microparts based on a Digital Light Processor (DLP) engine that achieves repeatable micron levels resolution. In addition, Nano’s Admatec Division supplies printing from Powder to Part by powder-based shaping & sintering technologies, from design to serial production of Powder Metallurgical & Ceramic parts or devices. The Admaflex 130 & 300 3D printing machines for ceramics and metals are modular DLP printing systems on one platform with customer-friendly software enabling full parameter accessibility & control and unique vision-based process monitoring. 

For more information, please visit www.nano-di.com.

Forward-Looking Statements 
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Nano Dimension’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Nano Dimension could differ materially from those described in or implied by the statements in this press release. For example, Nano Dimension is using forward-looking statements when it discusses the potential for growth of approximately 300% in full year 2022 and 10 times from 2020 to 2022, the ability of the Company to execute on its vision and business plans, including without needing to raise more capital, its future growth both organically and from acquisitions, its ability to sell complementary products, its commitment, vision and aim to build an ecofriendly and intelligent distributed secured network of 3D printers & roll-in adjacent industrial machine-learning-led-digitized manufacturing and self-learning and self-improving machines, that if contraction of multiples and valuations will be sustained, the Company expects to take advantage of its frugal approach to cash management during the unreasonable “market-inflation” during 2020 to early 2022, and that if acquisitions will withstand more reasonable prices, the Company hopes to show attractive synergistic growth from M&A activity. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Nano Dimension’s Annual Report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on March 31, 2022, and in any subsequent filings with the SEC. Except as otherwise required by law, Nano Dimension undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Nano Dimension is not responsible for the contents of third-party websites. 

NANO DIMENSION INVESTOR RELATIONS CONTACT

Yael Sandler, CFO | ir@nano-di.com 

Unaudited Consolidated Statements of Financial Position as at

			September 30,								December 31
(In thousands of USD)			2021				2022				2021(*)
			(Unaudited)				(Unaudited)
Assets
Cash and cash equivalents				1,127,778				370,197				853,626
Bank deposits				257,613				650,111				437,598
Restricted deposits				165				77				148
Trade receivables				1,223				5,929				3,422
Other receivables				3,459				2,925				5,902
Inventory				4,035				17,837				11,199
Total current assets				1,394,273				1,047,076				1,311,895
Restricted deposits				483				521				501
Bank deposits				-				28,404				64,371
Investment in securities				-				139,707				-
Other long-term assets				-				1,282				1,007
Property plant and equipment, net				7,523				13,166				7,690
Right of use asset				4,869				13,972				4,491
Intangible assets				116,767				31,799				-
Total non-current assets				129,642				228,851				78,060
Total assets				1,523,915				1,275,927				1,389,955
Liabilities
Trade payables				1,796				2,925				2,833
Financial derivatives				4,775				8,189				14,910
Other payables				7,970				18,864				13,836
Current portion of other long-term liability				-				370				417
Total current liabilities				14,541				30,348				31,996
Liability in respect of government grants				1,910				1,507				1,560
Employee benefits				-				296				4,145
Liability in respect of warrants				5,523				124				3,347
Lease liability				3,577				10,519				3,336
Deferred tax liabilities				3,128				587				236
Loan from banks				-				785				1,104
Other long-term liabilities				-				180				-
Total non-current liabilities				14,138				13,998				13,728
Total liabilities				28,679				44,346				45,724
Equity
Non-controlling interests				572				865				875
Share capital				386,372				387,646				386,665
Share premium and capital reserves				1,257,980				1,291,290				1,266,027
Treasury shares				(1,509	)			(1,509	)			(1,509	)
Remeasurement of Net Defined Benefit liability (IAS 19)				-				3,127				-
Presentation currency translation reserve				1,431				(848	)			1,407
Accumulated loss				(149,610	)			(448,990	)			(309,234	)
Equity attributable to owners of the company				1,494,664				1,230,716				1,343,356
Total equity				1,495,236				1,231,581				1,344,231
Total liabilities and equity				1,523,915				1,275,927				1,389,955
(*) The December 31st , 2021, balances were derived from the Company’s audited annual financial statements.

Unaudited Consolidated Statements of Profit or Loss and Other Comprehensive Income

(In thousands of USD, except per share amounts)
  

		For the Nine-Month Period Ended September 30,								For the Three-Month Period Ended September 30,								For the Year ended December 31
		2021				2022				2021				2022				2021(*)
		(Unaudited)				(Unaudited)				(Unaudited)				(Unaudited)
Revenues		2,962				31,529				1,340				9,998				10,493
Cost of revenues			1,380				21,159				696				7,428				5,730
Cost of revenues - amortization of inventory and assets recognized in business combination and technology			772				3,990				281				771				3,641
Total cost of revenues			2,152				25,149				977				8,199				9,371
Gross profit			810				6,380				363				1,799				1,122
Research and development expenses, net			26,587				54,770				13,726				18,535				41,686
Sales and marketing expenses			15,023				29,075				6,301				9,652				22,713
General and administrative expenses			13,174				21,366				4,843				7,417				19,644
Impairment losses			-				-				-				-				140,290
Operating loss			(53,974	)			(98,831	)			(24,507	)			(33,805	)			(223,211	)
Finance income			13,065				13,826				6,036				7,001				17,909
Finance expense			910				56,132				282				40,282				428
Loss before taxes on income			(41,819	)			(141,137	)			(18,753	)			(67,086	)			(205,730	)
Tax income (expense)			648				742				498				(47	)			4,906
Total loss after tax			(41,171	)			(140,395	)			(18,255	)			(67,133	)			(200,824	)
Total loss attributable to:
Non-controlling interests			(18	)			(639	)			(18	)			(202	)			(47	)
Owners of the Company			(41,153	)			(139,756	)			(18,237	)			(66,931	)			(200,777	)
Basic loss per share			(0.17	)			(0.54	)			(0.07	)			(0.26	)			(0.81	)
Other comprehensive income items that after initial recognition in comprehensive income were or will be transferred to profit or loss
Foreign currency translation differences for foreign operations			-				(2,351	)			-				(1,113	)			(46	)
Remeasurement of net defined benefit liability (IAS 19), net of tax			-				3,127				-				-				-
Total comprehensive loss			(41,171	)			(139,619	)			(18,255	)			(68,246	)			(200,870	)
Comprehensive loss attributable to non-controlling interests			-				(735	)			-				(247	)			(69	)
Comprehensive loss attributable to owners of the Company			(41,171	)			(138,884	)			(18,255	)			(67,999	)			(200,801	)
(*)  The December 31st, 2021, balances were derived from the Company’s audited annual financial statements.

Consolidated Statements of Changes in Equity (Unaudited)
(In thousands of USD)

				Share				Foreign
				premium				currency						Non-
		Share		and capital		Treasury		translation		Accumulated				controlling		Total
		capital		reserves		shares		reserve		loss		Total		interests		equity
For the nine months ended September 30, 2022:		Thousands USD		Thousands USD		Thousands USD		Thousands USD		Thousands USD		Thousands USD		Thousands USD		Thousands USD
Balance as of January 1, 2022		386,665		1,266,027		(1509	)	1,407		(309,234	)	1,343,356		875		1,344,231
Investment of non-controlling party in subsidiary		-		-		-		-		-		-		725		725
Loss for the period		-		-		-		-		(139,756	)	(139,756	)	(639	)	(140,395	)
Other comprehensive loss for the year, net of tax		-		3,127		-		(2,255	)	-		872		(96	)	776
Exercise of options		981		(981	)	-		-		-		-		-		-
Share-based payment acquired		-		(744	)	-		-		-		(744	)	-		(744	)
Share-based payments		-		26,988		-		-		-		26,988		-		26,988
Balance as of September 30, 2022		387,646		1,294,417		(1509	)	-848		(448,990	)	1,230,716		865		1,231,581

Consolidated Statements of Changes in Equity (Unaudited)
(In thousands of USD)

				Share				Foreign
				premium				currency						Non-
		Share		and capital		Treasury		translation		Accumulated				controlling		Total
		capital		reserves		shares		reserve		loss		Total		interests		equity
For the three months ended September 30, 2022:		Thousands USD		Thousands USD		Thousands USD		Thousands USD		Thousands USD		Thousands USD		Thousands USD		Thousands USD
Balance as of June 30, 2022		387,312		1,287,451		(1509	)	220		(382,059	)	1,291,415		553		1,291,968
Investment of non-controlling party in subsidiary		-		-		-		-		-		-		559		559
Loss for the period		-		-		-		-		-66,931		(66931	)	(202	)	(67,133	)
Other comprehensive loss for the year, net of tax		-		-		-		(1068	)	-		(1068	)	(45	)	(1113	)
Exercise of options		334		(334	)	-		-		-		-		-		-
Share-based payment acquired		-		-		-		-		-		-		-		-
Share-based payments		-		7,300		-		-		-		7,300		-		7,300
Balance as of September 30, 2022		387,646		1,294,417		(1509	)	(848	)	(448,990	)	1,230,716		865		1,231,581

Consolidated Statements of Cash Flows (Unaudited)
(In thousands of USD)

		For the Nine-Month Period Ended September 30th,								For the Three-Month Period Ended September 30th,								For the Year ended December 31st,
		2021				2022				2021				2022				2021(*)
Cash flow from operating activities:
Net loss			(41,171	)			(140,395	)			(18,255	)			(67,133	)			(200,824	)
Adjustments:
Depreciation and amortization			4,978				6,084				2,392				3,228				7,383
Impairment losses			-				-				-				-				140,290
Financing expenses (income), net			(1,799	)			9,089				(499	)			(3,466	)			(6,873	)
Revaluation of financial liabilities accounted at fair value			(10,356	)			(4,851	)			(5,255	)			(1,934	)			(10,608	)
Loss from disposal of property plant and equipment and right-of-use assets			72				91				30				97				567
Increase in deferred tax			(734	)			(1,441	)			(499	)			(109	)			(5,013	)
Revaluation of financial assets accounted at fair value			-				38,068				-				38,681				-
Share-based payments			21,503				26,637				10,186				7,300				29,782
Salary expenses paid by non-controlling interest (NCI)			-				216				-				50				-
			13,664				73,893				6,355				43,847				155,528
Changes in assets and liabilities:
Decrease (increase) in inventory			(591	)			(3,384	)			85				(1,506	)			2,382
Decrease (increase) in other receivables			(9	)			3,574				(130	)			3,871				(429	)
Decrease (increase) in trade receivables			(510	)			(1,761	)			(371	)			198				(449	)
Increase (decrease) in other payables			(70	)			1,333				836				(64	)			1,139
Increase (decrease) in employee benefits			-				1,101				-				(635	)			-
Increase (decrease) in trade payables			629				(42	)			218				(881	)			74
			(551	)			821				638				983				2,717
Net cash used in operating activities			(28,058	)			(65,681	)			(11,262	)			(22,303	)			(42,579	)
Cash flow from investing activities:
Investment in bank deposits and loans, net			(171,929	)			(187,412	)			104,490				(140,921	)			(416,019	)
Interest received			2,621				4,634				910				2,143				3,706
Change in restricted bank deposits			(31	)			(16	)			(3	)			59				(32	)
Acquisition of property plant and equipment			(2,165	)			(6,059	)			(1,150	)			(1,520	)			(9,761	)
Payment of a liability to pay a contingent consideration of business combination			-				(10,708	)			-				(709	)			-
Investment in shares measured in fair value through profit and loss			-				(177,775	)			-				(159,972	)			-
Acquisition of subsidiary, net of cash acquired			(62,644	)			(31,058	)			-				(12,899	)			(74,574	(
Net cash used in investing activities			(234,148	)			(408,394	)			104,247				(313,819	)			(496,680	)
Cash flow from financing activities:
Proceeds from issuance of Ordinary Shares, warrants and convertible notes, net			805,497				-				-				-				805,497
Exercise of warrants and options			150				-				-				-				212
Lease payments			(1,246	)			(3,088	)			(445	)			(1,207	)			(1,494	)
Proceeds from non-controlling interests			590				510				590				510				944
Repayment of long-term bank debt			-				(303	)			-				(85	)			(814	)
Amounts recognized in respect of government grants liability, net			(7	)			(132	)			(35	)			(39	)			(96	)
Share-based payment acquired			-				(744	)			-				-				-
Interest and other fees paid			(5	)			(95	)			22				(42	)			(70	)
Net cash provided by financing activities			804,979				(3,852	)			132				(863	)			804,179
Increase in cash			542,773				(477,927	)			93,117				(336,985	)			264,920
Cash at beginning of the period			585,338				853,626				1,034,838				706,220				585,338
Effect of exchange rate fluctuations on cash			(333	)			(5,502	)			(177	)			962				3,368
Cash at end of the period			1,127,778				370,197				1,127,778				370,197				853,626
Non-cash transactions:
Property plant and equipment acquired on credit			102				509				75				474				249
Conversion of convertible notes and warrants to equity			2,830				-				-				-				2,830
Acquisition of a right-of-use asset			1,890				11,536				90				286				1,919
Acquisition of financial assets in fair value through profit and loss against credit received			-				-				-				(2,158	)			-
(*)  The December 31st, 2021, balances were derived from the Company’s audited annual financial statements.

Non-IFRS measures

The following is a reconciliation of EBITDA and Adjusted EBITDA to loss before taxes, as calculated in accordance with International Financial Reporting Standards (“IFRS”):

		For the Nine -Month Period Ended September 30th,				For the Three-Month Period Ended September 30th,
		2022
		In thousands of USD
Loss before taxes on income			(141,137	)			(67,086	)
Depreciation and amortization (*)			7,617				2,345
Interest expense (income)			(8,962	)			(4,715	)
EBITDA (loss)			(142,482	)			(69,456	)
Finance expense for revaluation of assets and liabilities			33,368				36,535
Exchange rate differences			17,805				1,420
Share-based payments			26,637				7,300
Adjusted EBITDA (loss)			(64,672	)			(24,201	)
Gross profit			6,380				1,799
Amortization of inventory and intangibles			3,990				771
Adjusted gross profit, excluding amortization of intangible assets			10,370				2,570

(*) Including amortization of assets recognized in business combination and technology

EBITDA is a non-IFRS measure and is defined as total comprehensive loss before taxes excluding depreciation and amortization expenses and amortization of assets recognized in business combination and interest expense or income. We believe that EBITDA, as described above, should be considered in evaluating the Company’s operations. EBITDA facilitates the Company’s performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures, and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), and EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to the items mentioned above.

Adjusted EBITDA is a non-IFRS measure and is defined as total comprehensive loss before taxes excluding depreciation and amortization expenses and amortization of assets recognized in business combination, interest expenses or income, finance expense (income) for revaluation of assets and liabilities, exchange rate differences and share-based payments. We believe that Adjusted EBITDA, as described above, should also be considered in evaluating the Company’s operations. Like EBITDA, Adjusted EBITDA facilitates the Company’s performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures, and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), as well as from revaluation of assets and liabilities, exchange rate differences and share-based payment expenses. Adjusted EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to non-cash items, such as expenses related to revaluation, exchange rate differences and share-based payments.

Adjusted gross profit, excluding amortization of inventory and intangibles, is a non-IFRS measure and is defined as gross profit excluding amortization expenses. We believe that adjusted gross profit, as described above, should also be considered in evaluating the Company’s operations. Adjusted gross profit facilitates gross profit and gross margin comparisons from period to period and company to company by backing out potential differences caused by variations in amortization of inventory and intangible assets. Adjusted gross profit is useful to an investor in evaluating our performance because it enables investors, securities analysts and other interested parties to measure a company’s performance without regard to non-cash items, such as amortization expenses.

EBITDA, Adjusted EBITDA, and adjusted gross profit do not represent cash generated by operating activities in accordance with IFRS and should not be considered alternatives to net income (loss) as indicators of our operating performance or as measures of our liquidity. These measures should be considered in conjunction with net income (loss) as presented in our consolidated statements of profit or loss and other comprehensive income. Other companies may calculate these measures differently than we do.

FAQ

What were Nano Dimension's Q3 2022 revenue figures?

Nano Dimension reported revenues of $10 million for Q3 2022.

How much did Nano Dimension's revenue increase year-over-year?

Nano Dimension's revenue increased by 646% compared to Q3 2021.

What was the adjusted EBITDA for Nano Dimension in Q3 2022?

Adjusted EBITDA for Q3 2022 was negative $24.2 million.

What impact did the Russia-Ukraine conflict have on Nano Dimension's revenues?

The conflict led to a 75% revenue decline in Russia and Poland.

What is the backlog figure reported by Nano Dimension?

Nano Dimension reported a backlog of approximately $9 million.